Alex Biese

Revised guidelines also recommend mindfulness-based programs, yoga, acupressure and more to ease cancer-related fatigue.

CURE® spoke to an expert from Emory University in Atlanta about tonsil cancer, its “gold standard” treatment and potential side effects.

The Food and Drug Administration approved Jemperli with carboplatin and paclitaxel for primary advanced or recurrent endometrial cancer.

23andMe and 20 lung cancer advocacy organizations are working to improve lung cancer detection, risk reduction and care.

“Patients did great” with a four-drug regimen for multiple myeloma, an expert told CURE®.

From radiopharmaceuticals to hypofractionated radiation therapy, one expert explained the current landscape of radiation treatments for prostate cancer.

Reduced doses of radiation were shown to be effective for some patients with indolent orbital B-cell lymphoma, researchers said.

Researchers have found that among patients with certain melanoma, presurgical targeted therapy and immunotherapy can result in better pathologic response.

Citing toxicities and lack of efficacy, some are calling for caution when treating older patients with melanoma with immune checkpoint inhibitors.

A second dendritic cell vaccine has received fast track designation from the Food and Drug Administration.

Nubeqa plus androgen deprivation therapy displayed positive radiological progression-free survival results in early trial data.

For some patients with early non-small cell lung cancer and lung scarring, stereotactic ablative radiotherapy may be a viable option, research has shown.

One expert explains what patients with prostate cancer interested in clinical trial participation need to know.

A radiation oncology nurse explains the spectrum of side effects that can come with radiation for prostate cancer.

One radiation oncologist describes the advantages of MRI-guided SBRT when treating patients with prostate cancer.

While adherence to germline testing has been found to be low, one expert explained why tests findings could matter to patients.

As part of our “Speaking Out” video series, we look at the association between prostate cancer and mental health.

Updated data has been reported evaluating efti and Keytruda in PD-L1 negative recurrent or metastatic head and neck squamous cell carcinoma.

One expert from the University of Colorado Cancer Center explains the multidisciplinary aspect of sarcoma care to maximize patients’ functioning.

Patients with favorable-risk prostate cancer “should be aware that they don't need treatment right away,” one expert said.

The TIL therapy OBX-115 ‘may have the potential to address’ an unmet need among patients with metastatic or locally advanced melanoma.

Perioperative treatment with BRAF and MEK inhibitors was found to benefit some patients with stage 3 and 4 melanoma, according to a recent study.

One expert explains how bispecific antibodies are a ‘targeted and effective’ option for patients with multiple myeloma.

Patients with TGCT are encouraged to honestly discuss their pain with their care teams.

One expert explains the importance of a multidisciplinary care team for patients with TGCT.

TGCT is a non-malignant tumor, but one expert explained how it can similarly affect patients.

Tenosynovial giant cell tumors are not malignant but can impact patients’ quality of life, as one expert explained.

Systemic therapy and active surveillance can be viable options for patients with TGCT, as one expert explained.

Treatment with the CAR-T cell therapy Carvykti has been reported to improve survival among some patients with multiple myeloma.

The Food and Drug Administration recently approved Augtyro for the treatment of patients ages 12 and older with solid tumors harboring an NTRK gene fusion.